Abstract
AbstractWe describe our initial studies in the development of an orthotopic, genetically-defined, large animal model of breast cancer, using immunocompetent pigs. Primary mammary epithelial cells were isolated from the porcine gland. Primary mammary cells were immortalized with hTERT, and then transformed cell lines were generated from these immortalized cells with oncogenic KRAS and dominant negative p53. The transformed cell lines outperformed the primary cells in terms proliferation, population doubling time, soft agar growth, 2D migration, and Matrigel invasion. Three transformed cell lines were selected based on in vitro performance, and were able to grow tumors when injected subcutaneously in nude mice, with undifferentiated morphology. Tumorigenic porcine mammary cell lines were generated in this report.
Publisher
Cold Spring Harbor Laboratory
Reference30 articles.
1. Howlader N , Noone A , Krapcho M , Miller D , Brest A , Yu M , et al. Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review, 1975-2017. Bethesda, MD: National Cancer Institute.
2. Deaths: Final Data For 2017;Natl Vital Stat Rep [Internet],2019
3. NCCN, National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version 3.2020, Published March 6, 2020. Available from: www.nccn.org.
4. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
5. Advances in the Systemic Treatment of Triple-Negative Breast Cancer
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Large Animal Models of Breast Cancer;Frontiers in Oncology;2022-02-04